Literature DB >> 23054648

Acquired EVI1 rearrangement involved in the transformation from 5q- syndrome to pre-B lymphocytic leukemia in a Chinese patient.

Dandan Liu1, Suning Chen, Jinlan Pan, Mingqing Zhu, Ni Wu, Feng Zhu, Zixing Chen.   

Abstract

The anomalous EVI1 rearrangements/t(3;3)(q21;q26) is more frequently found in myelocytic malignancies. 5q- syndrome is a newly defined subtype of myelodysplastic syndrome (MDS) first proposed by the World Health Organization in 2001. Cases of acute lymphocytic leukemia (ALL) with 5q- anomaly or t(3;3)/EVI1 rearrangement have rarely been reported. We report a rare 5q- syndrome case which ultimately transformed to acute lymphocytic leukemia accompanied by a secondary cytogenetic anomaly of t(3;3)(q21;q26) and EVI1 rearrangement around 3 years after the diagnosis of 5q- syndrome. This rare case suggests that the 5q- clone of MDS may originate from a multipotent cell with a capacity to differentiate toward both myeloid and lymphoid lineages. It also indicates that although the t(3;3)/EVI1 rearrangement is mostly related to myelocytic neoplasms, the t(3;3)/EVI1-rearrangement may also play an important role in the development of ALL. The results of the necessary tests must be analyzed sufficiently prior to making a final diagnosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054648     DOI: 10.1007/s12185-012-1185-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  4 in total

1.  Hematologic malignancies, critical genes and representative pictures for 166 chromosome anomalies.

Authors:  Victor J Mahaffey; Jack L Spurbeck; Richard O Carlson; Gordon W Dewald
Journal:  Leuk Res       Date:  2004-12       Impact factor: 3.156

2.  Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome.

Authors:  R J Jaju; M Jones; J Boultwood; S Kelly; D Y Mason; J S Wainscoat; L Kearney
Journal:  Genes Chromosomes Cancer       Date:  2000-11       Impact factor: 5.006

Review 3.  Transformation of the 5q- syndrome to acute lymphoblastic leukemia: a report of two cases and review of the literature.

Authors:  Nicole M Agostino; Basil Ahmed; Dan Popescu; Shereen Gheith
Journal:  Int J Clin Exp Pathol       Date:  2011-03-22

4.  EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.

Authors:  M Konantz; M C André; M Ebinger; M Grauer; H Wang; S Grzywna; O C Rothfuss; S Lehle; O S Kustikova; H R Salih; R Handgretinger; F Fend; C Baum; L Kanz; L Quintanilla-Martinez; K Schulze-Osthoff; F Essmann; C Lengerke
Journal:  Leukemia       Date:  2012-07-25       Impact factor: 11.528

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.